Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Caribou Biosciences (CRBU) Revenue (2020 - 2025)

Caribou Biosciences has reported Revenue over the past 6 years, most recently at $3.9 million for Q4 2025.

  • Quarterly Revenue rose 89.74% to $3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.2 million through Dec 2025, up 11.66% year-over-year, with the annual reading at $11.2 million for FY2025, 11.66% up from the prior year.
  • Revenue was $3.9 million for Q4 2025 at Caribou Biosciences, up from $2.2 million in the prior quarter.
  • Over five years, Revenue peaked at $23.7 million in Q3 2023 and troughed at $1.5 million in Q2 2021.
  • The 5-year median for Revenue is $3.0 million (2022), against an average of $4.0 million.
  • Year-over-year, Revenue skyrocketed 616.38% in 2023 and then tumbled 91.45% in 2024.
  • A 5-year view of Revenue shows it stood at $2.6 million in 2021, then soared by 44.28% to $3.7 million in 2022, then dropped by 3.63% to $3.6 million in 2023, then crashed by 41.62% to $2.1 million in 2024, then skyrocketed by 89.74% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Revenue are $3.9 million (Q4 2025), $2.2 million (Q3 2025), and $2.7 million (Q2 2025).